BTK degrader BGB-16673 reduced tumor burden in 85% of patients from a high-risk, hard-to-treat group with relapsed / refractory CLL. Dr. Stephan Stilgenbauer from Ulm University and colleagues presented the results at the European Hematology Association (EHA) Annual Meeting in 2026.
More Videos in
Chronic Lymphocytic Leukemia (CLL) Content Hub
Join us for an informative webinar featuring Dr. Jennifer Woyach as she provides an overview of the current CLL treatment landscape and the many options available to patients…
Previous attempts to treat Christine’s Chronic Lymphocytic Leukemia (CLL) had failed. She participated in a clinical trial and subsequently went through a CAR T-cell transplant at the NCI-designated…
When it comes to CLL/SLL treatment, what’s the difference between BTK inhibitors and BCL-2 inhibitors? Understanding how these treatment approaches work and how they fit into the treatment…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Tune in for this comprehensive overview of Chronic Lymphocytic Leukemia (CLL), covering key risk factors, symptoms, and the decision-making process between monitoring and initiating treatment. This episode also…
In his first interview about his book “Ghosts in the Blood,” world-renowned hematologist/oncologist and CLL researcher Jeff Sharman, MD, takes us on a fascinating journey through the history…
Once you receive a diagnosis of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), it is common for the doctor to recommend “active surveillance” where the disease…
Profiling the metabolites produced by cells in Richter transformation could help researchers develop new targeted therapies in the future. Dr. Prajish Iyer from City of Hope National Comprehensive…
Chromosomes, FISH, and Why Cytogenetics Matter in CLL This episode explains how chromosome analysis helps predict prognosis in chronic lymphocytic leukemia, starting with the basics of how chromosomes…